Articles

The Society for Cardiovascular Angiography and Interventions (SCAI) this week published guiding principles and best practices for the development of radiation safety programs in cardiac...

January 10, 2011 – European CE mark approval was announced today for the Abbott, Absorb drug-eluting bioresorbable coronary stent. It is the first bioresorbable stent to gain regulatory approval...

For patients with severe hypertension that remains uncontrolled despite medical therapy, radiofrequency (RF) energy can be used in the renal vessels to block nerves involved with the sympathetic...

Advancements in newer 64-slice computed tomography (CT) systems and the introduction of 256- and 320-slice systems are helping to significantly reduce exposure to ionizing radiation.

Early defibrillation is often referred to as the “critical link in the chain of survival,” according to the American Heart Association (AHA). But even in a hospital setting, the time from when a...

March 18, 2010 – The U.S. Food and Drug Administration (FDA) today added a boxed warning to the anti-blood clotting drug Plavix (clopidogrel), alerting patients and healthcare professionals that...

March 16, 2010 — Lowering blood pressure to normal levels — below currently recommended levels — did not significantly reduce the combined risk of fatal or nonfatal cardiovascular disease events...

Organizers of the 2010 ACC Annual Scientific Session, March 13–16 in Atlanta, recently highlighted some of the changes to this year’s program.

On Saturday, March 13, the ACC is hosting the...

Editor’s note: Jerome Granato, M.D., is the medical director of the coronary care unit at Allegheny General Hospital in Pittsburgh, Pa. His facility started looking at ways to cut its...

March 3, 2010 – Pharmaceutical companies will struggle to profit from the cardiovascular disease (CVD) market over the next decade despite growing drug usage, according to new market research from...